Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac tissue engineering for replacement therapy.

Wolfram-Hubertus Zimmermann1, Thomas Eschenhagen

  • 1Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University of Erlangen-Nuremberg, Germany. zimmermann@pharmakologie.uni-erlangen.de

Heart Failure Reviews
|July 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human induced pluripotent stem cell cardiomyocytes for risk stratification of patients with LQT syndrome - ready for practice?

Cardiovascular research·2026
Same author

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

The New England journal of medicine·2026
Same author

Mechanical load inhibits cancer growth in mouse and human hearts.

Science (New York, N.Y.)·2026
Same author

Targeting Interleukin-8-Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome.

Circulation·2026
Same author

Models of the human heart for biomedical research: Opportunities and challenges.

Physiological reports·2026
Same author

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in <i>LMNA</i> Mutation-Induced Dilated Cardiomyopathy.

Circulation. Heart failure·2026

Cardiac tissue engineering, using engineered tissue constructs, shows promise for treating heart diseases. This approach requires careful selection of cell sources and scaffold materials for successful in vivo integration and function.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Cell-based therapies offer potential cures for myocardial infarction, heart failure, and congenital heart diseases.
  • Two main approaches exist: isolated cell implantation and in vitro engineered tissue construct implantation.
  • This review focuses on engineered cardiac tissue constructs.

Purpose of the Study:

  • To review recent advancements in cardiac tissue engineering using engineered tissue constructs.
  • To discuss materials and cell sources used in cardiac tissue engineering.
  • To address the obstacles and future perspectives of this therapeutic approach.

Main Methods:

  • Cardiac tissue engineering combines material sciences and cell biology.

Related Experiment Videos

  • Scaffold materials (e.g., gelatin, collagen, alginate, synthetic polymers) are used with cardiac cells.
  • In vitro reconstitution of tissue-like constructs with native myocardium properties is the goal.

    • Main Results:

    • Engineered constructs aim for coherent contractions, low diastolic tension, and syncytial action potential propagation.
    • For surgical repair, constructs need to integrate and remain contractile in vivo.
    • Size and mechanical properties are critical for repairing large myocardial defects.

    Conclusions:

    • Successful clinical application requires autologous or non-immunogenic cell sources and scaffolds to avoid immunosuppression.
    • Cardiac tissue engineering for replacement therapy is promising but still in its early stages.
    • The true clinical value of cardiac tissue engineering requires further thorough evaluation.